E. Fournier

发表

A Botrytis cinerea Emopamil Binding Domain Protein, Required for Full Virulence, Belongs to a Eukaryotic Superfamily Which Has Expanded in Euascomycetes

C. Levis, J. Pradier, C. Giraud, 2007, Eukaryotic Cell.

Interaction with the Phosphotyrosine Binding Domain/Phosphotyrosine Interacting Domain of SHC Is Required for the Transforming Activity of the FLT4/VEGFR3 Receptor Tyrosine Kinase*

D. Birnbaum, C. Turck, P. Pelicci, 1996, The Journal of Biological Chemistry.

SHC and SHIP phosphorylation and interaction in response to activation of the FLT3 receptor

D. Birnbaum, O. Rosnet, J. Borg, 1999, Leukemia.

F14512, a polyamine-vectorized anti-cancer drug, currently in clinical trials exhibits a marked preclinical anti-leukemic activity

J. Annereau, C. Bailly, L. Créancier, 2013, Leukemia.

In vivo micronucleus test using mouse hepatocytes.

E. Fournier, A. Cordier, C. Melcion, 1989, Mutation research.

The Role of the Shc Phosphotyrosine Interaction/Phosphotyrosine Binding Domain and Tyrosine Phosphorylation Sites in Polyoma Middle T Antigen-mediated Cell Transformation*

D. Birnbaum, J. Borg, S. Dilworth, 1997, The Journal of Biological Chemistry.

Flow cytometric detection of erythropoietic cytotoxicity in mouse bone marrow.

M. Maratrat, E. Fournier, A. Cordier, 1991, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

Structural basis for discrimination of 3-phosphoinositides by pleckstrin homology domains.

M. Lemmon, E. Skolnik, S. Isakoff, 2000, Molecular cell.

ERBIN: a basolateral PDZ protein that interacts with the mammalian ERBB2/HER2 receptor

D. Birnbaum, B. Margolis, J. Borg, 2000, Nature Cell Biology.

Antitumor activity of pyridoisoquinoline derivatives F91873 and F91874, novel multikinase inhibitors with activity against the anaplastic lymphoma kinase

J. Annereau, C. Bailly, A. Marchand, 2009, Anti-cancer drugs.

Role of tyrosine residues and protein interaction domains of SHC adaptor in VEGF Receptor 3 signaling

D. Birnbaum, B. Margolis, O. Rosnet, 1999, Oncogene.

Alpha-fetoprotein is a biomarker of unfolded protein response and altered proteostasis in hepatocellular carcinoma cells exposed to sorafenib.

B. Chauffert, O. Pluquet, C. François, 2016, Cancer letters.

Mutation at tyrosine residue 1337 abrogates ligand-dependent transforming capacity of the FLT4 receptor.

D. Birnbaum, P. Dubreuil, E. Fournier, 1995, Oncogene.

A third human CBL gene is on chromosome 19.

D. Birnbaum, M. Mattei, O. Rosnet, 1998, International journal of oncology.

Synthesis and activities towards resistant cancer cells of sulfone and sulfoxide griseofulvin derivatives.

E. Fournier, Frédéric Liéby-Muller, Frédéric Marion, 2015, Bioorganic & medicinal chemistry letters.

[Receptors for factors of the VEGF (Vascular Endothelial Growth Family)].

D. Birnbaum, E. Fournier, J. Borg, 1997, Bulletin du cancer.